Phase II/III (Integrated)

392 trials 186 recruiting

Filter these 392 trials by condition, country, sponsor and more.

Open in Search →

Evaluation of Glucocorticoids Plus Rituximab Compared to Glucocorticoids Plus Placebo for the Treatment of Patients With Newly-Diagnosed or … Pending

2024-516052-17-01 Patients with a diagnosis of IgAV according to Chapel H
Study of hydroxocobalamin at a new concentration for cobalamin-related remethylation disorders. Pending

2024-516862-12-00 Hydroxycobalamin deficiency
A phase 2 trial of capecitabine for recurrent and/or metastatic salivary duct carcinoma – CAESAR trial Pending

2024-516956-16-01 Salivary Duct Carcinoma
Evaluation of Botulinum TOXin type A in the treatment of Buerger’s disease Pending

2024-517772-38-00 Buerger's disease
An open-label phase 2/3 study to analyse the feasibility and evaluate the safety of intravenous administration of 99mTc-PSMA-T4 in patients … Pending

2024-519358-35-00 Feasibility analysis and safety evaluation of [99mTc]Tc
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending

2024-520218-23-00 Pulmonary Arterial Hypertension
A study of BMN 333 versus Vosoritide in Children with Achondroplasia Pending

2025-523811-12-00 Achondroplasia
The GranStone Trial Pending

2026-525608-85-00 Paraffin Oil Induced Granulomatous Disease
Changes in plaque characteristics after short-term statin therapy assessed with coronary CT (INTENSE) Pending

2025-522868-32-00 Coronary Artery Disease
The Surf trial Pending

2025-523898-42-00 Histologically confirmed solid malignancy (e.g., head a
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which has Spread and Caused Significant Body Weight Lo… Recruiting

2025-522093-36-00 Cancer cachexia 2026-05-20
Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS) Recruiting

2025-522257-19-00 Relapsing Multiple Sclerosis 2026-05-12
A Clinical Trial to Compare the Effectiveness and Safety of RO7771950 in Combination with Trastuzumab and Capecitabine, Versus Tucatinib in … Recruiting

2025-524498-17-00 Pretreated Unresectable Locally Advanced or Metastatic 2026-05-08
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients with Colorectal, Gastric, … Recruiting

2024-519384-18-00 Colorectal, Gastric, Ovarian or Pancreatic Cancer 2026-04-29
A study to investigate the efficacy and safety of frexalimab versus tacrolimus in adults undergoing kidney transplantation Recruiting

2025-521521-33-00 Kidney transplant rejection 2026-04-02
A Study in Pediatric Participants with Congenital Adrenal Hyperplasia Recruiting

2024-519578-38-00 Classic congenital adrenal hyperplasia 2026-03-30
Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Cancer-associated Cachexia 2026-03-26
A study to learn if DM199 drug is safe and whether it works better than placebo for treating acute ischemic stroke Recruiting

2024-513911-28-00 Acute Ischemic Stroke 2026-03-04
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. Recruiting

2025-522553-19-00 Symptomatic genetic and familial dilated cardiomyopathy 2026-02-25
A clinical study of enlicitide in children with high cholesterol (MK-0616-029) Recruiting

2024-519068-42-00 Heterozygous Familial Hypercholesterolemia in pediatr 2026-02-12
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting

2025-522052-13-00 Framework for Optimizing, Refining, and Unifying Manage 2025-12-24
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC. Recruiting

2024-516906-47-00 Locally Advanced or Metastatic Urothelial Carcinoma 2025-11-28
A study to assess the effect and safety of efgartigimod IV in participants from 12 years to less than 18 years of age with chronic Immune Th… Recruiting

2025-521055-23-00 Chronic Idiopathic thrombocytopenic purpura 2025-10-07
Dose-Selection, Safety and Efficacy Study with Open-Label Extension of Choline Chloride for Injection in Adolescent and Adult Patients with … Recruiting

2024-519496-26-00 Intestinal Failure 2025-09-25